FDA Increases OTC Monograph User Fees by 19 Percent for Fiscal 2022 Post author:PacConAdmin Post published:March 14, 2022 Post category:Drug Industry Daily The FDA has released its over-the-counter (OTC) monograph drug user fees for fiscal 2022. Source: Drug Industry Daily You Might Also Like Premier Trends Draws FDA Warning Letter for Making Drug Claims March 24, 2022 Form 483 Raises GMP Concerns About Apotek April 7, 2016 Generics Group Cries Foul Over Biosimilar Exclusivity Provision in USMCA Trade Deal October 1, 2018